Anales RANF

Simposium 14 : P2X7: A COMMON TARGET FOR BRAIN DISEASES? Chairs : Miguel Diaz-Hernandez (Madrid, Spain) / Tobias Engel (Dublin, Ireland) Content : Over the past recent years, the development of new transgenic animal models and highly specific pharmacological tools targeting the purinergic system has provided promising results in a great variety of different brain diseases. Purinergic signalling, in particular P2X7, has therefore gained an enormous interest, not only among brain researchers but also among pharma companies. Our symposium will include four experienced speakers at the forefront in their respective research field and who’s main interest constitutes the study of purinergic signalling, in particular P2X7. Our symposium will also include four talks from early stage researchers who will contribute with talks focusing on purinergic signalling in different brain diseases including topics on translational and basic research .

RkJQdWJsaXNoZXIy ODI4MTE=